Patent · US Active

2-(pyridin-2-ylamino)-pyrido[2,3, d]pyrimidin-7-ones

US7456168B2 · kind B2 · utility

20Cited by

2References

4Claims

0Family size

Assignee

WARNER-LAMBERT COMPANY LLC · US

Inventors

Mark Barvian · Ann Arbor, US
Richard John Booth · Ypsilanti, US
John Quin, III · Ann Arbor, US
Joseph Thomas Repine · Ann Arbor, US
Derek J. Sheehan · Dexter, US
Peter L. Toogood · Ann Arbor, US
Scott Norman Vanderwel · Ann Arbor, US
Hairong Zhou · Ann Arbor, US

Key dates

Filing date	Apr 11, 2007
Grant date	Nov 25, 2008
Priority date	—
Expiry date	Apr 11, 2027

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides substituted 2-aminopyridines useful in treating cell proliferative disorders. The novel compounds of the present invention are potent inhibitors of cyclin-dependent kinases 4 (cdk4).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.